A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

Clinical trial NCT05582993 · RECRUITING

Trial details

NCT number: NCT05582993
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Von Willebrand Disease (VWD)

Start date: 2024-11-06
Primary completion: 2030-04-11
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.